Literature DB >> 15009513

Melatonin reduces cholesterol accumulation and prooxidant state induced by high cholesterol diet in the plasma, the liver and probably in the aorta of C57BL/6J mice.

Göksel Sener1, Jale Balkan, Ugur Cevikbaş, Meral Keyer-Uysal, Müjdat Uysal.   

Abstract

We examined the hypolipidemic and antioxidative effects of melatonin in plasma, liver and aorta of C57BL/6J mice fed on a high cholesterol (HC) diet. Mice were fed normal mice chow containing 1.5% cholesterol and 0.5% cholic acid for 4 months with or without melatonin (10 mg/L in drinking water) treatment. HC diet was observed to increase cholesterol, triglyceride and diene conjugate (DC) levels in plasma and liver. There was a tendency towards an increase in cholesterol level in the aorta following HC diet. In addition, aortic DC levels were higher than those of control group. No fatty streaks or plaques developed in the aorta of mice following HC diet, but in some sections, derangement of the endothelial layer was detected. Melatonin treatment was found to reduce plasma, liver cholesterol and DC levels as well as liver triglyceride levels in hypercholesterolemic mice. Aortic cholesterol and DC levels were also reduced in hypercholesterolemic mice when given melatonin, although not statistically significant. There were no differences in aortic histopathological findings of mice fed on a HC diet with and without melatonin treatment. In conclusion, our results indicate that melatonin reduces HC diet-induced cholesterol accumulation and prooxidant state in the plasma, liver and probably in the aorta.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15009513     DOI: 10.1111/j.1600-079x.2004.00122.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  10 in total

Review 1.  Metabolic effects of melatonin on oxidative stress and diabetes mellitus.

Authors:  Shigeru Nishida
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

2.  Serum lipid levels in seasonal affective disorder.

Authors:  Edda Pjrek; Dietmar Winkler; David W Abramson; Anastasios Konstantinidis; Jürgen Stastny; Matthäus Willeit; Nicole Praschak-Rieder; Siegfried Kasper
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-12-05       Impact factor: 5.270

3.  Comparative antilipidemic effect of N-acetylcysteine and sesame oil administration in diet-induced hypercholesterolemic mice.

Authors:  Laskarina-Maria Korou; George Agrogiannis; Alkisti Pantopoulou; Ioannis S Vlachos; Dimitrios Iliopoulos; Theodoros Karatzas; Despoina N Perrea
Journal:  Lipids Health Dis       Date:  2010-03-06       Impact factor: 3.876

4.  Effects of melatonin on biochemical factors and food and water consumption in diabetic rats.

Authors:  Bahram Bibak; Monavareh Khalili; Ziba Rajaei; Mohammad Soukhtanloo; Mousa-Al-Reza Hadjzadeh; Parichehr Hayatdavoudi
Journal:  Adv Biomed Res       Date:  2014-08-19

Review 5.  Effects of Melatonin on Liver Injuries and Diseases.

Authors:  Jiao-Jiao Zhang; Xiao Meng; Ya Li; Yue Zhou; Dong-Ping Xu; Sha Li; Hua-Bin Li
Journal:  Int J Mol Sci       Date:  2017-03-23       Impact factor: 5.923

6.  The Effects of Melatonin in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial.

Authors:  Hassan Pakravan; Mehdi Ahmadian; Ali Fani; Davood Aghaee; Sareh Brumanad; Bahram Pakzad
Journal:  Adv Biomed Res       Date:  2017-04-17

7.  Melatonin activates ABCA1 via the BiP/NRF1 pathway to suppress high-cholesterol-induced apoptosis of mesenchymal stem cells.

Authors:  Jun Sung Kim; Young Hyun Jung; Hyun Jik Lee; Chang Woo Chae; Gee Euhn Choi; Jae Ryong Lim; Seo Yihl Kim; Joo Eun Lee; Ho Jae Han
Journal:  Stem Cell Res Ther       Date:  2021-02-05       Impact factor: 6.832

8.  Chronic Moderate Alcohol Intakes Accelerate SR-B1 Mediated Reverse Cholesterol Transport.

Authors:  Menghua Li; Yan Diao; Ying Liu; Hui Huang; Yanze Li; Peizhu Tan; Huan Liang; Qi He; Junhui Nie; Xingli Dong; Yang Wang; Lingyun Zhou; Xu Gao
Journal:  Sci Rep       Date:  2016-09-13       Impact factor: 4.379

9.  Can melatonin prevent or improve metabolic side effects during antipsychotic treatments?

Authors:  Maria-Cristina Porfirio; Juliana Paula Gomes de Almeida; Maddalena Stornelli; Silvia Giovinazzo; Diane Purper-Ouakil; Gabriele Masi
Journal:  Neuropsychiatr Dis Treat       Date:  2017-08-10       Impact factor: 2.570

10.  Melatonin Ameliorates the Progression of Atherosclerosis via Mitophagy Activation and NLRP3 Inflammasome Inhibition.

Authors:  Sai Ma; Jiangwei Chen; Jing Feng; Ran Zhang; Miaomiao Fan; Dong Han; Xiang Li; Congye Li; Jun Ren; Yabin Wang; Feng Cao
Journal:  Oxid Med Cell Longev       Date:  2018-09-04       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.